Treatment of acne vulgaris;Acnebehandling

Ugeskrift for Laeger

Volumn 162, Issue 50, 2000, Pages 6840-6844

  Jemec, Gregor B E ^b  

^a Medicinsk Afdeling   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; BENZOYL PEROXIDE; CLINDAMYCIN; DIANE; ERYTHROMYCIN; FUSIDATE SODIUM; ISOTRETINOIN; MICONAZOLE; RETINOIC ACID; TETRACYCLINE;

ACNE VULGARIS; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; FETOTOXICITY; HUMAN; MONOTHERAPY; PATHOGENESIS; REVIEW; SCAR FORMATION;

ACNE VULGARIS; ADMINISTRATION, TOPICAL; ANTI-BACTERIAL AGENTS; DERMATOLOGIC AGENTS; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; HUMANS; ISOTRETINOIN;

EID: 0034639194     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Kilkenny M, Merlin K, Plunkett A, Marks R. The prevalence of common skin conditions in Australian school students: 3. acne vulgaris. Br J Dermatol 1998; 139: 840-5.
2. Goulden V, Stables GI, Cunliffe WJ. Prevalence of facial acne in adults. J Am Acad Dermatol 1999; 41: 577-80.
3. Cunliffe WJ. Doctors should not change the way they prescribe for acne. Br Med J 1996; 312: 1101.
4. Layton AM, Henderson CA, Cunliffe WJ. A clinical evaluation of acne scarring and its incidence. Clin Exp Dermatol 1994; 19: 303-8.
5. Layton AM. Acne scarring - reviewing the need for early treatment of acne. J Dermatol Treatm 2000; 11: 3-6.
6. nd ed. Berlin: Springer Verlag, 1993.
7. Guy R, Kealey T. The effects of inflammatory cytokines on the isolated human sebaceous infundibulum. Invest Dermatol 1998; 110: 410-5.
8. Guy R, Kealy T. The organ-maintained human sebaceous gland. Dermatology 1998; 196: 16-20.
9. Deplowski D, Rosenfield RL. Role of hormones in pilosebaceous unit development. Endocrin Rev 2000; 21: 363-92.
10. Cooper AJ. Proprionibacterium acnes resistance to systemic antibiotics. Med J Aust 1998; 169: 259-61.
11. Holland KT, Holland DB, Cunliffe WJ, Cutcliffe AG. Detection of Proprionibacterioum acnes peptides which have stimulated an immune response in acne patients but not in normal individuals. Exp Dermatol 1993; 2: 12-6.
12. Layton AM, Morris C, Cunliffe WJ, Ingham E. Immunohistochemical investigation of evolving inflammation in lesions of acne vulgaris. Exp Dermatol 1998; 7: 191-7.
13. Webster GF, Leyden JJ, McGinley KJ, McArthur WP. Supression of polymorphonuclear leucocyte chemotactic factor production in Proprioni-bacterium acnes by subminimal inhibitory concentrations of tetracycline, ampicillin, minocycline and erythromycin. Antimicrob Agents Chemother 1982; 21: 770-2.
14. Markela M, Larjava H, Pirila E, Maisi P, Salo T, Sarsa T et al. Matrix metalloproteinase 2 (gelatinase 2) is related to migration of keratinocytes. Exp Cell Res 1999; 251: 67-78.
15. Jone H, Blanc D, Cunliffe WJ. 13-cis retinoic acid and acne. Lancet 1980; 2: 1048-9.
16. Plewig G, Wagner A, Braun-Falco O. Oral treatment of severe forms of acne with 13-cis retinoiuc acid. Clinical results. MMW Munch Med Wochenschr 1980; 122: 602-11.
17. Orfanos CE, Zouboulis CC, Almond-Roesler B, Geilen CC. Current use and future potential role of retinoids in dermatology. Drugs 1997; 53: 358-88.
18. Garner SE, Eady EA, Popescu C, Newton J, Po AWL. Minocycline for acne vulgaris: efficacy and safety. I: The Cochrane Library, Issue 3, 2000. Oxford: Update Software.
19. Allen BS, Smith JG. Various parameters for grading acne vulgaris. Arch dermatol 1982; 118: 23-7.
20. Ortonne JP. Oral isotretinoin treatment policy. Do we all agree? Dermatology 1997; 195 (suppl 1): 34-40.
21. Jemec BIE, Jemec GBE. The principles and practice of skin excisions. Amsterdam: Elsevier, 1996.